CreditReports.dk
HomeScreen companies

Zerion Pharma A/S Financials, key figures and credit report

CVR number: 40169229 Established 2019 Industry: 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Company contact details
Fruebjergvej 3, 2100 København Ø jdh@zerion.eu tel: 40968018 www.zerion.eu
Net sales 3 377.6 kDKK FY 2025 -2.2% vs 2024
EBIT margin - 367.2 % FY 2025 +17.1 pp vs 2024
Net debt 7 994.9 kDKK FY 2025 +42.5% vs 2024
Quick ratio 2.9 FY 2025 +0.9 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales1 932.773 273.333 559.963 452.023 377.65
Other operating income1 680.0067.7517.58
Purchases during the financial year-5 179.06-8 351.67-5 085.67-4 803.72-3 459.06
External services-5 148.39-5 902.06-3 727.68-4 482.58-4 727.75
Gross profit-6 714.67-10 912.65-5 253.39-5 834.28-4 791.58
Employee benefit expenses-6 245.37-9 538.15-6 156.56-6 896.75-7 076.09
Total depreciation- 219.90- 441.03- 537.20- 537.20- 536.54
EBIT-13 179.94-20 891.83-11 947.15-13 268.23-12 404.22
Other financial income5.283.832.970.8568.43
Other financial expenses- 571.13-1 241.10-1 561.47-1 592.57- 801.57
Net income from associates (fin.)12 359.60
Pre-tax profit-13 745.79-22 129.10-13 505.64-2 500.35-13 137.35
Income taxes2 611.743 271.782 403.752 280.332 307.00
Net earnings-11 134.05-18 857.32-11 101.89- 220.02-10 830.35

Assets (kDKK)

2021
2022
2023
2024
2025
Intangible assets total
Machinery and equipment2 114.472 945.732 625.902 088.701 552.16
Tangible assets total2 114.472 945.732 625.902 088.701 552.16
Other shares and similar rights of ownership20.0020.00
Investments total158.49158.49
Long term receivables total
Inventories total
Current trade debtors595.01818.19492.33184.611 007.80
Current amounts owed by group member comp.677.861 709.87
Prepayments and accrued income578.7376.18443.96369.71
Current other receivables1 153.181 161.76467.83299.90316.88
Current deferred tax assets2 611.743 393.962 510.002 350.992 307.02
Short term receivables total4 938.675 373.913 546.333 957.315 711.28
Cash and bank deposits6 644.494 103.622 299.973 466.603 632.96
Cash and cash equivalents6 644.494 103.622 299.973 466.603 632.96
Balance sheet total (assets)13 697.6212 423.258 472.219 671.1011 054.90

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital459.48520.93640.02907.261 024.86
Other reserves904.53
Retained earnings9 807.748 378.31-3 268.64-2 945.715 389.55
Profit of the financial year-11 134.05-18 857.32-11 101.89- 220.02-10 830.35
Shareholders equity total- 866.83-9 958.08-13 730.51-2 258.47-3 511.41
Non-current loans from credit institutions10 403.8317 768.0219 196.388 051.6711 180.18
Non-current deferred tax liabilities175.65181.00187.70193.52199.32
Non-current liabilities total10 579.4717 949.0219 384.088 245.1911 379.50
Current loans from credit institutions837.99922.491 025.36
Current trade creditors2 366.481 987.241 536.081 304.301 467.94
Current owed to participating447.63
Other non-interest bearing current liabilities1 618.501 607.08360.071 354.731 271.23
Current liabilities total3 984.984 432.312 818.643 684.383 186.80
Balance sheet total (liabilities)13 697.6212 423.258 472.219 671.1011 054.90
Page generated